247 related articles for article (PubMed ID: 17470545)
41. Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids.
Enkhtuya J; Kawamoto K; Kobayashi Y; Uchida I; Rana N; Makino SI
Microbiology (Reading); 2006 Oct; 152(Pt 10):3103-3110. PubMed ID: 17005989
[TBL] [Abstract][Full Text] [Related]
42. Effect of the lower molecular capsule released from the cell surface of Bacillus anthracis on the pathogenesis of anthrax.
Makino S; Watarai M; Cheun HI; Shirahata T; Uchida I
J Infect Dis; 2002 Jul; 186(2):227-33. PubMed ID: 12134259
[TBL] [Abstract][Full Text] [Related]
43. In vivo Bacillus anthracis gene expression requires PagR as an intermediate effector of the AtxA signalling cascade.
Mignot T; Couture-Tosi E; Mesnage S; Mock M; Fouet A
Int J Med Microbiol; 2004 Apr; 293(7-8):619-24. PubMed ID: 15149039
[TBL] [Abstract][Full Text] [Related]
44. Bacillus cereus G9241 makes anthrax toxin and capsule like highly virulent B. anthracis Ames but behaves like attenuated toxigenic nonencapsulated B. anthracis Sterne in rabbits and mice.
Wilson MK; Vergis JM; Alem F; Palmer JR; Keane-Myers AM; Brahmbhatt TN; Ventura CL; O'Brien AD
Infect Immun; 2011 Aug; 79(8):3012-9. PubMed ID: 21576337
[TBL] [Abstract][Full Text] [Related]
45. Differential contribution of Bacillus anthracis toxins to pathogenicity in two animal models.
Levy H; Weiss S; Altboum Z; Schlomovitz J; Glinert I; Sittner A; Shafferman A; Kobiler D
Infect Immun; 2012 Aug; 80(8):2623-31. PubMed ID: 22585968
[TBL] [Abstract][Full Text] [Related]
46. In vivo characterization of an Hfq protein encoded by the Bacillus anthracis virulence plasmid pXO1.
Keefer AB; Asare EK; Pomerantsev AP; Moayeri M; Martens C; Porcella SF; Gottesman S; Leppla SH; Vrentas CE
BMC Microbiol; 2017 Mar; 17(1):63. PubMed ID: 28288571
[TBL] [Abstract][Full Text] [Related]
47. AtxA, a Bacillus anthracis global virulence regulator.
Fouet A
Res Microbiol; 2010 Nov; 161(9):735-42. PubMed ID: 20863885
[TBL] [Abstract][Full Text] [Related]
48. Formation and composition of the Bacillus anthracis endospore.
Liu H; Bergman NH; Thomason B; Shallom S; Hazen A; Crossno J; Rasko DA; Ravel J; Read TD; Peterson SN; Yates J; Hanna PC
J Bacteriol; 2004 Jan; 186(1):164-78. PubMed ID: 14679236
[TBL] [Abstract][Full Text] [Related]
49. Bacillus anthracis spore interactions with mammalian cells: relationship between germination state and the outcome of in vitro.
Gut IM; Tamilselvam B; Prouty AM; Stojkovic B; Czeschin S; van der Donk WA; Blanke SR
BMC Microbiol; 2011 Feb; 11():46. PubMed ID: 21356113
[TBL] [Abstract][Full Text] [Related]
50. CodY regulation is required for full virulence and heme iron acquisition in Bacillus anthracis.
Château A; van Schaik W; Six A; Aucher W; Fouet A
FASEB J; 2011 Dec; 25(12):4445-56. PubMed ID: 21911592
[TBL] [Abstract][Full Text] [Related]
51. Importance of nitric oxide synthase in the control of infection by Bacillus anthracis.
Raines KW; Kang TJ; Hibbs S; Cao GL; Weaver J; Tsai P; Baillie L; Cross AS; Rosen GM
Infect Immun; 2006 Apr; 74(4):2268-76. PubMed ID: 16552057
[TBL] [Abstract][Full Text] [Related]
52. The Bacillus anthracis protein MprF is required for synthesis of lysylphosphatidylglycerols and for resistance to cationic antimicrobial peptides.
Samant S; Hsu FF; Neyfakh AA; Lee H
J Bacteriol; 2009 Feb; 191(4):1311-9. PubMed ID: 19074395
[TBL] [Abstract][Full Text] [Related]
53. Delineating the effect of host environmental signals on a fully virulent strain of Bacillus anthracis using an integrated transcriptomics and proteomics approach.
Panda G; Basak T; Tanwer P; Sengupta S; dos Santos VA; Bhatnagar R
J Proteomics; 2014 Jun; 105():242-65. PubMed ID: 24406299
[TBL] [Abstract][Full Text] [Related]
54. Construction of a rhamnose mutation in Bacillus anthracis affects adherence to macrophages but not virulence in guinea pigs.
Bozue JA; Parthasarathy N; Phillips LR; Cote CK; Fellows PF; Mendelson I; Shafferman A; Friedlander AM
Microb Pathog; 2005 Jan; 38(1):1-12. PubMed ID: 15652290
[TBL] [Abstract][Full Text] [Related]
55. Transcriptional profiling of the Bacillus anthracis life cycle in vitro and an implied model for regulation of spore formation.
Bergman NH; Anderson EC; Swenson EE; Niemeyer MM; Miyoshi AD; Hanna PC
J Bacteriol; 2006 Sep; 188(17):6092-100. PubMed ID: 16923876
[TBL] [Abstract][Full Text] [Related]
56. Macrophages release tumor necrosis factor alpha and interleukin-12 in response to intracellular Bacillus anthracis spores.
Pickering AK; Merkel TJ
Infect Immun; 2004 May; 72(5):3069-72. PubMed ID: 15102824
[TBL] [Abstract][Full Text] [Related]
57. GeneChip analyses of global transcriptional responses of murine macrophages to the lethal toxin of Bacillus anthracis.
Comer JE; Galindo CL; Chopra AK; Peterson JW
Infect Immun; 2005 Mar; 73(3):1879-85. PubMed ID: 15731093
[TBL] [Abstract][Full Text] [Related]
58. Cytokine response to infection with Bacillus anthracis spores.
Pickering AK; Osorio M; Lee GM; Grippe VK; Bray M; Merkel TJ
Infect Immun; 2004 Nov; 72(11):6382-9. PubMed ID: 15501768
[TBL] [Abstract][Full Text] [Related]
59. Capsule synthesis by Bacillus anthracis is required for dissemination in murine inhalation anthrax.
Drysdale M; Heninger S; Hutt J; Chen Y; Lyons CR; Koehler TM
EMBO J; 2005 Jan; 24(1):221-7. PubMed ID: 15616593
[TBL] [Abstract][Full Text] [Related]
60. Glucose-dependent activation of Bacillus anthracis toxin gene expression and virulence requires the carbon catabolite protein CcpA.
Chiang C; Bongiorni C; Perego M
J Bacteriol; 2011 Jan; 193(1):52-62. PubMed ID: 20971911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
